Starpharma Holdings Limited (ASX:SPL – Get Free Report) insider Jeff Davies bought 879,687 shares of the business’s stock in a transaction on Friday, June 28th. The shares were acquired at an average price of A$0.09 ($0.06) per share, with a total value of A$80,051.52 ($53,367.68).
Starpharma Stock Performance
The company has a quick ratio of 5.65, a current ratio of 5.60 and a debt-to-equity ratio of 9.08.
Starpharma Company Profile
See Also
- Five stocks we like better than Starpharma
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- AbbVie Stock: A Perfect Dip for Investors to Buy
- Comparing and Trading High PE Ratio Stocks
- Forget NVIDIA: Super Micro Computer Stock Leads in Momentum
- Stock Analyst Ratings and Canadian Analyst Ratings
- GitLab Stock Rebounds: The Inside Story of Its Comeback
Receive News & Ratings for Starpharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Starpharma and related companies with MarketBeat.com's FREE daily email newsletter.